The U.S. Food and Drug Administration (FDA) has approved paforacyanin (Cytalux) as an injectable contrast agent for adults with lung cancer. of new approvalGranted following priority...
In what may be the first estimate of bacterial deaths worldwide, researchers found that 33 bacterial pathogens were responsible for more than 1 in 7 deaths...
Recent Comments